Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health.

MLA

Seyed Khoei, Nazlisadat, et al. “Mild Hyperbilirubinaemia as an Endogenous Mitigator of Overweight and Obesity: Implications for Improved Metabolic Health.” Atherosclerosis (00219150), vol. 269, Feb. 2018, pp. 306–11. EBSCOhost, https://doi.org/10.1016/j.atherosclerosis.2017.12.021.

APA

Seyed Khoei, N., Grindel, A., Wallner, M., Mölzer, C., Doberer, D., Marculescu, R., Bulmer, A., & Wagner, K.-H. (2018). Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health. Atherosclerosis (00219150), 269, 306–311. https://doi.org/10.1016/j.atherosclerosis.2017.12.021

Chicago

Seyed Khoei, Nazlisadat, Annemarie Grindel, Marlies Wallner, Christine Mölzer, Daniel Doberer, Rodrig Marculescu, Andrew Bulmer, and Karl-Heinz Wagner. 2018. “Mild Hyperbilirubinaemia as an Endogenous Mitigator of Overweight and Obesity: Implications for Improved Metabolic Health.” Atherosclerosis (00219150) 269 (February): 306–11. doi:10.1016/j.atherosclerosis.2017.12.021.